Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Glucagon-like peptide-1 (7–36) amide response to low versus high glycaemic index preloads in overweight subjects with and without type II diabetes mellitus

European Journal of Clinical Nutrition volume 61, pages 1364–1372 (2007)Cite this article

Abstract

Background and objective:

Glucagon-like-peptide-1 (7–36) amide (GLP-1) is an insulin secretagogue and potential treatment for type II diabetes mellitus. An alternative to GLP-1 administration is endogenous dietary stimulation. We described a greater GLP-1 release following ingestion of liquids versus solids. We add to this work studying the effect of fluid preloads with differing glycaemic indices (GI) on the metabolic response to a meal.

Subjects and design:

GLP-1, insulin and glucose responses were measured in six overweight individuals and six subjects with type II diabetes on three occasions, after preload (milk, low GI; Ovaltine Light, high GI; or water, non-nutritive control) and meal ingestion.

Results:

In people with and without diabetes, the high GI preload produced the greatest glucose incremental area under the curve (IAUC)0–20, followed by the low GI preload, and water (P<0.001). In both groups, insulin IAUC0–20 was higher following high and low GI preloads compared with water (NS). In people without diabetes, the GLP-1 response was higher when high and low GI preloads were consumed compared with water (P=0.041), with no significant difference between nutritive preloads. GLP-1 response did not differ between preloads in people with diabetes. Despite initial differences, total IAUCs0–200 for biochemical variables did not differ by preload.

Conclusion:

We confirm that nutritive liquids stimulate GLP-1 to a greater extent than water in subjects without diabetes; however, this does not influence subsequent meal-induced response. The GI of preloads does not influence the degree of GLP-1 stimulation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

References

  • Adam TC, Westerterp-Plantenga MS (2005). Nutrient-stimulated GLP-1 release in normal-weight men and women. Horm Metab Res 37, 111–117.

    Article  CAS  Google Scholar 

  • Adam TC, Westerterp-Plantenga MS (2005). Glucagon-like peptide-1 release and satiety after a nutrient challenge in normal-weight and obese subjects. Br J Nutr 93, 845–851.

    Article  CAS  Google Scholar 

  • Brand-Miller J, Holt SH, de Jong V, Petocz P (2003). Cocoa powder increases postprandial insulinemia in lean young adults. J Nutr 133, 3149–3152.

    Article  CAS  Google Scholar 

  • Brynes AE, Frost GS, Edwards CM, Ghatei MA, Bloom SR (1998). Plasma glucagon-like peptide-1 (7–36) amide (GLP-1) response to liquid phase, solid phase, and meals of differing lipid composition. Nutrition 14, 433–466.

    Article  CAS  Google Scholar 

  • Brynes AE, Lee JL, Brighton RE, Leeds AR, Dornhorst A, Frost GS (2003). A low glycemic diet significantly improves the 24-h blood glucose profile in people with type 2 diabetes, as assessed using the continuous glucose minimed monitor. Diabetes Care 26, 548–549.

    Article  Google Scholar 

  • Flint A, Raben A, Astrup A, Holst JJ (1998). Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest 101, 515–520.

    Article  CAS  Google Scholar 

  • Frost G, Keogh B, Smith D, Akinsanya K, Leeds A (1996). The effect of low-glycemic carbohydrate on insulin and glucose response in vivo and in vitro in patients with coronary heart disease. Metabolism 45, 669–672.

    Article  CAS  Google Scholar 

  • Gutniak MK, Linde B, Holst JJ, Efendic S (1994). Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM. Diabetes Care 17, 1039–1044.

    Article  CAS  Google Scholar 

  • Holt SH, Miller JC, Petocz P (1997). An insulin index of foods: the insulin demand generated by 1000-KJ portions of common foods. Am J Clin Nutr 66, 1264–1276.

    Article  CAS  Google Scholar 

  • Hoyt G, Hickey MS, Cordain L (2005). Dissociation of the glycaemic and insulinaemic responses to whole and skimmed milk. Br J Nutr 93, 175–177.

    Article  CAS  Google Scholar 

  • Hui H, Wright C, Perfetti R (2001). Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 50, 785–796.

    Article  CAS  Google Scholar 

  • Jarvi AE, Karlstrom BE, Granfeldt YE, Bjorck IE, Asp NG, Vessby BO (1999). Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients. Diabetes Care 22, 10–18.

    Article  CAS  Google Scholar 

  • Jenkins DJ, Wolever TM, Taylor RH, Barker H, Fielden H, Baldwin JM et al. (1981). Glycemic index of foods: a physiological basis for carbohydrate exchange. Am J Clin Nutr 34, 362–366.

    Article  CAS  Google Scholar 

  • Kjems LL, Holst JJ, Volund A, Madsbad S (2003). The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects. Diabetes 52, 380–386.

    Article  CAS  Google Scholar 

  • Kreymann B, Williams G, Ghatei MA, Bloom SR (1987). Glucagon-like peptide-1 7–36: a physiological incretin in man. Lancet 2, 1300–1344.

    Article  CAS  Google Scholar 

  • Layer P, Holst JJ, Grandt D, Goebell H (1995). Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Dig Dis Sci 40, 1074–1082.

    Article  CAS  Google Scholar 

  • Lugari R, Dei Cas A, Ugolotti D, Finardi L, Barilli AL, Ognibene C et al. (2002). Evidence for early impairment of glucagon-like peptide 1-induced insulin secretion in human type 2 (non insulin-dependent) diabetes. Horm Metab Res 34, 150–154.

    Article  CAS  Google Scholar 

  • Nauck MA, Heimesaat MM, Orskov C, Holst JJ, Ebert R, Creutzfeldt W (1993). Preserved incretin activity of glucagon-like peptide 1 [7–36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus. J Clin Invest 91, 301–307.

    Article  CAS  Google Scholar 

  • Nilsson M, Stenberg M, Frid AH, Holst JJ, Bjorck IM (2004). Glycemia and insulinemia in healthy subjects after lactose-equivalent meals of milk and other food proteins: the role of plasma amino acids and incretins. Am J Clin Nutr 80, 1246–1253.

    Article  CAS  Google Scholar 

  • Ostman EM, Liljeberg Elmstahl HG, Bjorck IM (2001). Inconsistency between glycemic and insulinemic responses to regular and fermented milk products. Am J Clin Nutr 74, 96–100.

    Article  CAS  Google Scholar 

  • O’Donovan DG, Doran S, Feinle-Bisset C, Jones KL, Meyer JH, Wishart JM et al. (2004). Effect of variations in small intestinal glucose delivery on plasma glucose, insulin, and incretin hormones in healthy subjects and type 2 diabetes. J Clin Endocrinol Metab 89, 3431–3435.

    Article  Google Scholar 

  • Ranganath LR, Beety JM, Morgan LM, Wright JW, Howland R, Marks V (1996). Attenuated GLP-1 secretion in obesity: cause or consequence? Gut 38, 916–919.

    Article  CAS  Google Scholar 

  • Rawlins MD, Henderson DB, Hijab AR (1997). Pharmacokinetics of paracetamol (acetaminophen) after intravenous and oral administration. Eur J Clin Pharmacol 11, 283–286.

    Article  Google Scholar 

  • Shively CA, Apgar JL, Tarka Jr SM (1986). Postprandial glucose and insulin responses to various snacks of equivalent carbohydrate content in normal subjects. Am J Clin Nutr 43, 335–342.

    Article  CAS  Google Scholar 

  • Tarling MM, Toner CC, Withington PS, Baxter MK, Whelpton R, Goldhill DR (1997). A model of gastric emptying using paracetamol absorption in intensive care patients. Intensive Care Med 23, 256–260.

    Article  CAS  Google Scholar 

  • Teff KL, Engelman K (1996). Palatability and dietary restraint: effect on cephalic phase insulin release in women. Physiol Behav 60, 567–573.

    Article  CAS  Google Scholar 

  • Todd JF, Wilding JP, Edwards CM, Khan FA, Ghatei MA, Bloom SR (1999). Glucagon-like peptide-1 (GLP-1): a trial of treatment in non-insulin-dependent diabetes mellitus. Eur J Clin Invest 27, 533–536.

    Article  Google Scholar 

  • Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK et al. (2001). Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86, 3717–3723.

    Article  CAS  Google Scholar 

  • Truswell AS (1992). Glycaemic index of foods. Eur J Clin Nutr 46 (Suppl 2), S91–S101.

    PubMed  Google Scholar 

  • Verdich C, Toubro S, Buemann B, Lysgard Madsen J, Juul Holst J, Astrup A (2001). The role of postprandial releases of insulin and incretin hormones in meal-induced satiety – effect of obesity and weight reduction. Int J Obes Relat Metab Disord 25, 1206–1214.

    Article  CAS  Google Scholar 

  • Vilsboll T, Krarup T, Deacon CF, Madsbad S, Holst JJ (2001). Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50, 609–613.

    Article  CAS  Google Scholar 

  • Vilsboll T, Krarup T, Sonne J, Madsbad S, Volund A, Juul AG et al. (2003). Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus. J Clin Endocrinol Metab 88, 2706–2713.

    Article  CAS  Google Scholar 

  • Zander M, Madsbad S, Madsen JL, Holst JJ (2002). Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study. Lancet 359, 824–830.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Dr John Meek for undertaking the Paracetamol analysis.

Author information

Authors and Affiliations

  1. Nutrition and Dietetic Research Group, Hammersmith Hospital, London, UK

    J E Milton, C S Sananthanan & G S Frost

  2. Endocrine Unit, Imperial College Faculty of Medicine, Hammersmith Hospital, London, UK

    M Patterson, M A Ghatei & S R Bloom

Authors
  1. J E Milton
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C S Sananthanan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Patterson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M A Ghatei
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S R Bloom
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G S Frost
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G S Frost.

Additional information

Guarantor: GS Frost.

Contributors: JEM was responsible for the experimental design, subject recruitment, data collection and analysis, biochemical analysis and writing of the paper. CSS was responsible for data collection and some biochemical analysis. MP and MAG were responsible for biochemical analysis. GSF and SRB were responsible for experimental design and data analysis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Milton, J., Sananthanan, C., Patterson, M. et al. Glucagon-like peptide-1 (7–36) amide response to low versus high glycaemic index preloads in overweight subjects with and without type II diabetes mellitus. Eur J Clin Nutr 61, 1364–1372 (2007). https://doi.org/10.1038/sj.ejcn.1602654

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602654

Keywords

This article is cited by

Search

Advanced search

Quick links